nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Ifosfamide—hematologic cancer	0.0244	0.0394	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0244	0.0394	CbGbCtD
Oxycodone—CYP3A7—Imatinib—hematologic cancer	0.0233	0.0376	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0233	0.0376	CbGbCtD
Oxycodone—CYP3A5—Daunorubicin—hematologic cancer	0.0228	0.0368	CbGbCtD
Oxycodone—CYP2D6—Lomustine—hematologic cancer	0.0222	0.0358	CbGbCtD
Oxycodone—CYP3A5—Thalidomide—hematologic cancer	0.0208	0.0335	CbGbCtD
Oxycodone—CYP3A5—Teniposide—hematologic cancer	0.0198	0.032	CbGbCtD
Oxycodone—CYP2D6—Idarubicin—hematologic cancer	0.0198	0.0319	CbGbCtD
Oxycodone—CYP3A5—Ifosfamide—hematologic cancer	0.0183	0.0295	CbGbCtD
Oxycodone—CYP3A5—Imatinib—hematologic cancer	0.0175	0.0282	CbGbCtD
Oxycodone—CYP2D6—Hydroxyurea—hematologic cancer	0.0168	0.0271	CbGbCtD
Oxycodone—CYP3A4—Bexarotene—hematologic cancer	0.0152	0.0245	CbGbCtD
Oxycodone—CYP2D6—Bortezomib—hematologic cancer	0.0146	0.0236	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0146	0.0235	CbGbCtD
Oxycodone—CYP3A7—Irinotecan—hematologic cancer	0.0146	0.0235	CbGbCtD
Oxycodone—CYP3A4—Busulfan—hematologic cancer	0.0141	0.0228	CbGbCtD
Oxycodone—CYP3A4—Lomustine—hematologic cancer	0.0141	0.0228	CbGbCtD
Oxycodone—CYP3A5—Dasatinib—hematologic cancer	0.0141	0.0227	CbGbCtD
Oxycodone—CYP3A7—Vincristine—hematologic cancer	0.0127	0.0205	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0127	0.0205	CbGbCtD
Oxycodone—CYP3A4—Thiotepa—hematologic cancer	0.0126	0.0203	CbGbCtD
Oxycodone—CYP3A5—Irinotecan—hematologic cancer	0.0109	0.0176	CbGbCtD
Oxycodone—CYP2D6—Imatinib—hematologic cancer	0.0107	0.0173	CbGbCtD
Oxycodone—CYP3A4—Methoxsalen—hematologic cancer	0.00979	0.0158	CbGbCtD
Oxycodone—CYP2D6—Nilotinib—hematologic cancer	0.00975	0.0157	CbGbCtD
Oxycodone—CYP2D6—Vinorelbine—hematologic cancer	0.00967	0.0156	CbGbCtD
Oxycodone—CYP3A7—Dexamethasone—hematologic cancer	0.0096	0.0155	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.0096	0.0155	CbGbCtD
Oxycodone—CYP3A5—Vincristine—hematologic cancer	0.00955	0.0154	CbGbCtD
Oxycodone—CYP3A4—Bortezomib—hematologic cancer	0.00931	0.015	CbGbCtD
Oxycodone—CYP3A4—Daunorubicin—hematologic cancer	0.00891	0.0144	CbGbCtD
Oxycodone—CYP3A5—Etoposide—hematologic cancer	0.00875	0.0141	CbGbCtD
Oxycodone—CYP3A4—Cytarabine—hematologic cancer	0.00786	0.0127	CbGbCtD
Oxycodone—CYP3A4—Teniposide—hematologic cancer	0.00774	0.0125	CbGbCtD
Oxycodone—CYP3A5—Dexamethasone—hematologic cancer	0.0072	0.0116	CbGbCtD
Oxycodone—CYP3A4—Ifosfamide—hematologic cancer	0.00714	0.0115	CbGbCtD
Oxycodone—CYP3A4—Imatinib—hematologic cancer	0.00682	0.011	CbGbCtD
Oxycodone—CYP3A4—Ruxolitinib—hematologic cancer	0.00643	0.0104	CbGbCtD
Oxycodone—CYP3A4—Nilotinib—hematologic cancer	0.0062	0.01	CbGbCtD
Oxycodone—CYP3A4—Vinorelbine—hematologic cancer	0.00615	0.00991	CbGbCtD
Oxycodone—CYP2D6—Vinblastine—hematologic cancer	0.00596	0.00961	CbGbCtD
Oxycodone—CYP3A4—Triamcinolone—hematologic cancer	0.00562	0.00907	CbGbCtD
Oxycodone—CYP3A4—Dasatinib—hematologic cancer	0.00548	0.00883	CbGbCtD
Oxycodone—CYP3A4—Mitoxantrone—hematologic cancer	0.00541	0.00873	CbGbCtD
Oxycodone—CYP3A4—Betamethasone—hematologic cancer	0.00482	0.00778	CbGbCtD
Oxycodone—CYP3A4—Prednisolone—hematologic cancer	0.00476	0.00767	CbGbCtD
Oxycodone—CYP3A4—Prednisone—hematologic cancer	0.0045	0.00725	CbGbCtD
Oxycodone—CYP2D6—Dexamethasone—hematologic cancer	0.00441	0.00712	CbGbCtD
Oxycodone—CYP3A4—Irinotecan—hematologic cancer	0.00426	0.00687	CbGbCtD
Oxycodone—CYP3A4—Vinblastine—hematologic cancer	0.00379	0.00611	CbGbCtD
Oxycodone—CYP3A4—Vincristine—hematologic cancer	0.00373	0.00601	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—hematologic cancer	0.00366	0.0059	CbGbCtD
Oxycodone—CYP3A4—Etoposide—hematologic cancer	0.00341	0.0055	CbGbCtD
Oxycodone—CYP3A4—Dexamethasone—hematologic cancer	0.00281	0.00452	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—hematologic cancer	0.00233	0.00375	CbGbCtD
Oxycodone—Naloxone—CREB1—hematologic cancer	0.00164	0.443	CrCbGaD
Oxycodone—Naltrexone—UGT1A1—hematologic cancer	0.000795	0.214	CrCbGaD
Oxycodone—Codeine—SLC22A1—hematologic cancer	0.000487	0.131	CrCbGaD
Oxycodone—Naloxone—ESR1—hematologic cancer	0.000319	0.0861	CrCbGaD
Oxycodone—Naltrexone—ABCB1—hematologic cancer	0.000186	0.0502	CrCbGaD
Oxycodone—Naloxone—ALB—hematologic cancer	0.000142	0.0383	CrCbGaD
Oxycodone—Naloxone—ABCB1—hematologic cancer	0.000136	0.0366	CrCbGaD
Oxycodone—Diarrhoea—Etoposide—hematologic cancer	2.19e-05	6.75e-05	CcSEcCtD
Oxycodone—Anorexia—Prednisone—hematologic cancer	2.19e-05	6.74e-05	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—hematologic cancer	2.19e-05	6.73e-05	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—hematologic cancer	2.18e-05	6.72e-05	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—hematologic cancer	2.18e-05	6.72e-05	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—hematologic cancer	2.17e-05	6.7e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Dexamethasone—hematologic cancer	2.17e-05	6.69e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Betamethasone—hematologic cancer	2.17e-05	6.69e-05	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—hematologic cancer	2.17e-05	6.69e-05	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—hematologic cancer	2.17e-05	6.69e-05	CcSEcCtD
Oxycodone—Flatulence—Epirubicin—hematologic cancer	2.17e-05	6.68e-05	CcSEcCtD
Oxycodone—Tension—Epirubicin—hematologic cancer	2.16e-05	6.65e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.16e-05	6.64e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.16e-05	6.64e-05	CcSEcCtD
Oxycodone—Dysgeusia—Epirubicin—hematologic cancer	2.16e-05	6.64e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Triamcinolone—hematologic cancer	2.14e-05	6.6e-05	CcSEcCtD
Oxycodone—Nervousness—Epirubicin—hematologic cancer	2.14e-05	6.58e-05	CcSEcCtD
Oxycodone—Back pain—Epirubicin—hematologic cancer	2.13e-05	6.56e-05	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—hematologic cancer	2.12e-05	6.54e-05	CcSEcCtD
Oxycodone—Malaise—Methotrexate—hematologic cancer	2.12e-05	6.53e-05	CcSEcCtD
Oxycodone—Dizziness—Etoposide—hematologic cancer	2.12e-05	6.53e-05	CcSEcCtD
Oxycodone—Muscle spasms—Epirubicin—hematologic cancer	2.12e-05	6.52e-05	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—hematologic cancer	2.11e-05	6.51e-05	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—hematologic cancer	2.11e-05	6.51e-05	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—hematologic cancer	2.11e-05	6.49e-05	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—hematologic cancer	2.11e-05	6.48e-05	CcSEcCtD
Oxycodone—Chills—Doxorubicin—hematologic cancer	2.1e-05	6.47e-05	CcSEcCtD
Oxycodone—Urticaria—Dexamethasone—hematologic cancer	2.1e-05	6.45e-05	CcSEcCtD
Oxycodone—Urticaria—Betamethasone—hematologic cancer	2.1e-05	6.45e-05	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.09e-05	6.45e-05	CcSEcCtD
Oxycodone—Dizziness—Prednisolone—hematologic cancer	2.09e-05	6.44e-05	CcSEcCtD
Oxycodone—Asthenia—Triamcinolone—hematologic cancer	2.09e-05	6.42e-05	CcSEcCtD
Oxycodone—Abdominal pain—Dexamethasone—hematologic cancer	2.09e-05	6.42e-05	CcSEcCtD
Oxycodone—Body temperature increased—Dexamethasone—hematologic cancer	2.09e-05	6.42e-05	CcSEcCtD
Oxycodone—Body temperature increased—Betamethasone—hematologic cancer	2.09e-05	6.42e-05	CcSEcCtD
Oxycodone—Abdominal pain—Betamethasone—hematologic cancer	2.09e-05	6.42e-05	CcSEcCtD
Oxycodone—Nausea—Cisplatin—hematologic cancer	2.08e-05	6.4e-05	CcSEcCtD
Oxycodone—Insomnia—Prednisone—hematologic cancer	2.08e-05	6.4e-05	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—hematologic cancer	2.06e-05	6.35e-05	CcSEcCtD
Oxycodone—Pruritus—Triamcinolone—hematologic cancer	2.06e-05	6.33e-05	CcSEcCtD
Oxycodone—Cough—Methotrexate—hematologic cancer	2.05e-05	6.32e-05	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—hematologic cancer	2.05e-05	6.31e-05	CcSEcCtD
Oxycodone—Ill-defined disorder—Epirubicin—hematologic cancer	2.04e-05	6.29e-05	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—hematologic cancer	2.04e-05	6.28e-05	CcSEcCtD
Oxycodone—Vomiting—Etoposide—hematologic cancer	2.04e-05	6.28e-05	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—hematologic cancer	2.04e-05	6.27e-05	CcSEcCtD
Oxycodone—Anaemia—Epirubicin—hematologic cancer	2.03e-05	6.27e-05	CcSEcCtD
Oxycodone—Agitation—Epirubicin—hematologic cancer	2.02e-05	6.23e-05	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—hematologic cancer	2.02e-05	6.23e-05	CcSEcCtD
Oxycodone—Rash—Etoposide—hematologic cancer	2.02e-05	6.22e-05	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—hematologic cancer	2.02e-05	6.22e-05	CcSEcCtD
Oxycodone—Headache—Etoposide—hematologic cancer	2.01e-05	6.18e-05	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—hematologic cancer	2.01e-05	6.18e-05	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—hematologic cancer	2e-05	6.17e-05	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—hematologic cancer	2e-05	6.17e-05	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—hematologic cancer	2e-05	6.17e-05	CcSEcCtD
Oxycodone—Tension—Doxorubicin—hematologic cancer	2e-05	6.16e-05	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—hematologic cancer	2e-05	6.15e-05	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—hematologic cancer	1.99e-05	6.14e-05	CcSEcCtD
Oxycodone—Rash—Prednisolone—hematologic cancer	1.99e-05	6.14e-05	CcSEcCtD
Oxycodone—Dermatitis—Prednisolone—hematologic cancer	1.99e-05	6.13e-05	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.99e-05	6.12e-05	CcSEcCtD
Oxycodone—Malaise—Epirubicin—hematologic cancer	1.99e-05	6.11e-05	CcSEcCtD
Oxycodone—Fatigue—Prednisone—hematologic cancer	1.98e-05	6.1e-05	CcSEcCtD
Oxycodone—Headache—Prednisolone—hematologic cancer	1.98e-05	6.1e-05	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—hematologic cancer	1.98e-05	6.09e-05	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—hematologic cancer	1.98e-05	6.09e-05	CcSEcCtD
Oxycodone—Vertigo—Epirubicin—hematologic cancer	1.98e-05	6.09e-05	CcSEcCtD
Oxycodone—Syncope—Epirubicin—hematologic cancer	1.97e-05	6.08e-05	CcSEcCtD
Oxycodone—Leukopenia—Epirubicin—hematologic cancer	1.97e-05	6.07e-05	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—hematologic cancer	1.97e-05	6.07e-05	CcSEcCtD
Oxycodone—Constipation—Prednisone—hematologic cancer	1.96e-05	6.05e-05	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—hematologic cancer	1.96e-05	6.03e-05	CcSEcCtD
Oxycodone—Palpitations—Epirubicin—hematologic cancer	1.95e-05	5.99e-05	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—hematologic cancer	1.94e-05	5.96e-05	CcSEcCtD
Oxycodone—Loss of consciousness—Epirubicin—hematologic cancer	1.93e-05	5.96e-05	CcSEcCtD
Oxycodone—Dizziness—Triamcinolone—hematologic cancer	1.92e-05	5.92e-05	CcSEcCtD
Oxycodone—Cough—Epirubicin—hematologic cancer	1.92e-05	5.92e-05	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—hematologic cancer	1.92e-05	5.91e-05	CcSEcCtD
Oxycodone—Convulsion—Epirubicin—hematologic cancer	1.91e-05	5.87e-05	CcSEcCtD
Oxycodone—Infection—Methotrexate—hematologic cancer	1.91e-05	5.87e-05	CcSEcCtD
Oxycodone—Nausea—Etoposide—hematologic cancer	1.9e-05	5.86e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—hematologic cancer	1.89e-05	5.83e-05	CcSEcCtD
Oxycodone—Asthenia—Betamethasone—hematologic cancer	1.89e-05	5.83e-05	CcSEcCtD
Oxycodone—Asthenia—Dexamethasone—hematologic cancer	1.89e-05	5.83e-05	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.89e-05	5.82e-05	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—hematologic cancer	1.88e-05	5.8e-05	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—hematologic cancer	1.88e-05	5.8e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—hematologic cancer	1.88e-05	5.78e-05	CcSEcCtD
Oxycodone—Nausea—Prednisolone—hematologic cancer	1.88e-05	5.78e-05	CcSEcCtD
Oxycodone—Chest pain—Epirubicin—hematologic cancer	1.87e-05	5.77e-05	CcSEcCtD
Oxycodone—Arthralgia—Epirubicin—hematologic cancer	1.87e-05	5.77e-05	CcSEcCtD
Oxycodone—Myalgia—Epirubicin—hematologic cancer	1.87e-05	5.77e-05	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—hematologic cancer	1.87e-05	5.76e-05	CcSEcCtD
Oxycodone—Anxiety—Epirubicin—hematologic cancer	1.87e-05	5.75e-05	CcSEcCtD
Oxycodone—Pruritus—Betamethasone—hematologic cancer	1.87e-05	5.75e-05	CcSEcCtD
Oxycodone—Pruritus—Dexamethasone—hematologic cancer	1.87e-05	5.75e-05	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—hematologic cancer	1.86e-05	5.74e-05	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.86e-05	5.73e-05	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—hematologic cancer	1.86e-05	5.72e-05	CcSEcCtD
Oxycodone—Discomfort—Epirubicin—hematologic cancer	1.85e-05	5.7e-05	CcSEcCtD
Oxycodone—Vomiting—Triamcinolone—hematologic cancer	1.85e-05	5.69e-05	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—hematologic cancer	1.84e-05	5.66e-05	CcSEcCtD
Oxycodone—Rash—Triamcinolone—hematologic cancer	1.83e-05	5.64e-05	CcSEcCtD
Oxycodone—Dry mouth—Epirubicin—hematologic cancer	1.83e-05	5.64e-05	CcSEcCtD
Oxycodone—Dermatitis—Triamcinolone—hematologic cancer	1.83e-05	5.64e-05	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—hematologic cancer	1.83e-05	5.64e-05	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—hematologic cancer	1.83e-05	5.64e-05	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—hematologic cancer	1.83e-05	5.63e-05	CcSEcCtD
Oxycodone—Urticaria—Prednisone—hematologic cancer	1.83e-05	5.62e-05	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—hematologic cancer	1.82e-05	5.61e-05	CcSEcCtD
Oxycodone—Headache—Triamcinolone—hematologic cancer	1.82e-05	5.61e-05	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—hematologic cancer	1.82e-05	5.59e-05	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—hematologic cancer	1.82e-05	5.59e-05	CcSEcCtD
Oxycodone—Confusional state—Epirubicin—hematologic cancer	1.81e-05	5.58e-05	CcSEcCtD
Oxycodone—Diarrhoea—Betamethasone—hematologic cancer	1.8e-05	5.56e-05	CcSEcCtD
Oxycodone—Diarrhoea—Dexamethasone—hematologic cancer	1.8e-05	5.56e-05	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—hematologic cancer	1.8e-05	5.54e-05	CcSEcCtD
Oxycodone—Oedema—Epirubicin—hematologic cancer	1.8e-05	5.53e-05	CcSEcCtD
Oxycodone—Anaphylactic shock—Epirubicin—hematologic cancer	1.8e-05	5.53e-05	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—hematologic cancer	1.79e-05	5.52e-05	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—hematologic cancer	1.79e-05	5.51e-05	CcSEcCtD
Oxycodone—Infection—Epirubicin—hematologic cancer	1.79e-05	5.5e-05	CcSEcCtD
Oxycodone—Cough—Doxorubicin—hematologic cancer	1.78e-05	5.47e-05	CcSEcCtD
Oxycodone—Shock—Epirubicin—hematologic cancer	1.77e-05	5.44e-05	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—hematologic cancer	1.76e-05	5.43e-05	CcSEcCtD
Oxycodone—Nervous system disorder—Epirubicin—hematologic cancer	1.76e-05	5.43e-05	CcSEcCtD
Oxycodone—Tachycardia—Epirubicin—hematologic cancer	1.75e-05	5.4e-05	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.75e-05	5.39e-05	CcSEcCtD
Oxycodone—Skin disorder—Epirubicin—hematologic cancer	1.75e-05	5.37e-05	CcSEcCtD
Oxycodone—Dizziness—Dexamethasone—hematologic cancer	1.74e-05	5.37e-05	CcSEcCtD
Oxycodone—Dizziness—Betamethasone—hematologic cancer	1.74e-05	5.37e-05	CcSEcCtD
Oxycodone—Hyperhidrosis—Epirubicin—hematologic cancer	1.74e-05	5.35e-05	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—hematologic cancer	1.74e-05	5.35e-05	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—hematologic cancer	1.73e-05	5.34e-05	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—hematologic cancer	1.73e-05	5.34e-05	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—hematologic cancer	1.73e-05	5.34e-05	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—hematologic cancer	1.73e-05	5.32e-05	CcSEcCtD
Oxycodone—Nausea—Triamcinolone—hematologic cancer	1.73e-05	5.32e-05	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—hematologic cancer	1.72e-05	5.31e-05	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.72e-05	5.3e-05	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—hematologic cancer	1.71e-05	5.28e-05	CcSEcCtD
Oxycodone—Anorexia—Epirubicin—hematologic cancer	1.71e-05	5.27e-05	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—hematologic cancer	1.71e-05	5.27e-05	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—hematologic cancer	1.71e-05	5.26e-05	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—hematologic cancer	1.7e-05	5.22e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—hematologic cancer	1.69e-05	5.21e-05	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—hematologic cancer	1.69e-05	5.2e-05	CcSEcCtD
Oxycodone—Hypotension—Epirubicin—hematologic cancer	1.68e-05	5.17e-05	CcSEcCtD
Oxycodone—Vomiting—Dexamethasone—hematologic cancer	1.68e-05	5.16e-05	CcSEcCtD
Oxycodone—Vomiting—Betamethasone—hematologic cancer	1.68e-05	5.16e-05	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—hematologic cancer	1.68e-05	5.16e-05	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—hematologic cancer	1.67e-05	5.14e-05	CcSEcCtD
Oxycodone—Rash—Dexamethasone—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Rash—Betamethasone—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Dermatitis—Betamethasone—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Dermatitis—Dexamethasone—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.66e-05	5.1e-05	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—hematologic cancer	1.66e-05	5.1e-05	CcSEcCtD
Oxycodone—Headache—Dexamethasone—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Oxycodone—Headache—Betamethasone—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Oxycodone—Infection—Doxorubicin—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Oxycodone—Asthenia—Prednisone—hematologic cancer	1.65e-05	5.08e-05	CcSEcCtD
Oxycodone—Pain—Methotrexate—hematologic cancer	1.64e-05	5.06e-05	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.64e-05	5.04e-05	CcSEcCtD
Oxycodone—Shock—Doxorubicin—hematologic cancer	1.64e-05	5.04e-05	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—hematologic cancer	1.63e-05	5.02e-05	CcSEcCtD
Oxycodone—Pruritus—Prednisone—hematologic cancer	1.63e-05	5e-05	CcSEcCtD
Oxycodone—Insomnia—Epirubicin—hematologic cancer	1.63e-05	5e-05	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—hematologic cancer	1.62e-05	5e-05	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—hematologic cancer	1.61e-05	4.97e-05	CcSEcCtD
Oxycodone—Paraesthesia—Epirubicin—hematologic cancer	1.61e-05	4.97e-05	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.61e-05	4.95e-05	CcSEcCtD
Oxycodone—Dyspnoea—Epirubicin—hematologic cancer	1.6e-05	4.93e-05	CcSEcCtD
Oxycodone—Somnolence—Epirubicin—hematologic cancer	1.6e-05	4.92e-05	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—hematologic cancer	1.58e-05	4.88e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—hematologic cancer	1.58e-05	4.87e-05	CcSEcCtD
Oxycodone—Dyspepsia—Epirubicin—hematologic cancer	1.58e-05	4.87e-05	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—hematologic cancer	1.57e-05	4.84e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.57e-05	4.83e-05	CcSEcCtD
Oxycodone—Nausea—Betamethasone—hematologic cancer	1.57e-05	4.82e-05	CcSEcCtD
Oxycodone—Nausea—Dexamethasone—hematologic cancer	1.57e-05	4.82e-05	CcSEcCtD
Oxycodone—Decreased appetite—Epirubicin—hematologic cancer	1.56e-05	4.81e-05	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—hematologic cancer	1.55e-05	4.78e-05	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.55e-05	4.78e-05	CcSEcCtD
Oxycodone—Fatigue—Epirubicin—hematologic cancer	1.55e-05	4.77e-05	CcSEcCtD
Oxycodone—Pain—Epirubicin—hematologic cancer	1.54e-05	4.73e-05	CcSEcCtD
Oxycodone—Constipation—Epirubicin—hematologic cancer	1.54e-05	4.73e-05	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—hematologic cancer	1.53e-05	4.7e-05	CcSEcCtD
Oxycodone—Dizziness—Prednisone—hematologic cancer	1.52e-05	4.68e-05	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—hematologic cancer	1.52e-05	4.67e-05	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—hematologic cancer	1.52e-05	4.67e-05	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.51e-05	4.66e-05	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—hematologic cancer	1.5e-05	4.63e-05	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—hematologic cancer	1.49e-05	4.6e-05	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—hematologic cancer	1.48e-05	4.56e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Epirubicin—hematologic cancer	1.48e-05	4.56e-05	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—hematologic cancer	1.48e-05	4.55e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.47e-05	4.52e-05	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—hematologic cancer	1.46e-05	4.51e-05	CcSEcCtD
Oxycodone—Vomiting—Prednisone—hematologic cancer	1.46e-05	4.5e-05	CcSEcCtD
Oxycodone—Rash—Prednisone—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—hematologic cancer	1.45e-05	4.45e-05	CcSEcCtD
Oxycodone—Headache—Prednisone—hematologic cancer	1.44e-05	4.43e-05	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.44e-05	4.42e-05	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—hematologic cancer	1.43e-05	4.41e-05	CcSEcCtD
Oxycodone—Urticaria—Epirubicin—hematologic cancer	1.43e-05	4.4e-05	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—hematologic cancer	1.42e-05	4.38e-05	CcSEcCtD
Oxycodone—Pain—Doxorubicin—hematologic cancer	1.42e-05	4.38e-05	CcSEcCtD
Oxycodone—Abdominal pain—Epirubicin—hematologic cancer	1.42e-05	4.37e-05	CcSEcCtD
Oxycodone—Body temperature increased—Epirubicin—hematologic cancer	1.42e-05	4.37e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—hematologic cancer	1.41e-05	4.36e-05	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—hematologic cancer	1.38e-05	4.24e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—hematologic cancer	1.37e-05	4.22e-05	CcSEcCtD
Oxycodone—Nausea—Prednisone—hematologic cancer	1.36e-05	4.2e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.36e-05	4.19e-05	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—hematologic cancer	1.36e-05	4.18e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Epirubicin—hematologic cancer	1.32e-05	4.08e-05	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—hematologic cancer	1.32e-05	4.07e-05	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—hematologic cancer	1.31e-05	4.05e-05	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—hematologic cancer	1.31e-05	4.05e-05	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—hematologic cancer	1.31e-05	4.05e-05	CcSEcCtD
Oxycodone—Asthenia—Epirubicin—hematologic cancer	1.29e-05	3.97e-05	CcSEcCtD
Oxycodone—Pruritus—Epirubicin—hematologic cancer	1.27e-05	3.91e-05	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—hematologic cancer	1.27e-05	3.91e-05	CcSEcCtD
Oxycodone—Diarrhoea—Epirubicin—hematologic cancer	1.23e-05	3.79e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—hematologic cancer	1.22e-05	3.77e-05	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—hematologic cancer	1.22e-05	3.76e-05	CcSEcCtD
Oxycodone—Rash—Methotrexate—hematologic cancer	1.21e-05	3.73e-05	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—hematologic cancer	1.21e-05	3.72e-05	CcSEcCtD
Oxycodone—Headache—Methotrexate—hematologic cancer	1.2e-05	3.7e-05	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—hematologic cancer	1.19e-05	3.67e-05	CcSEcCtD
Oxycodone—Dizziness—Epirubicin—hematologic cancer	1.19e-05	3.66e-05	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—hematologic cancer	1.18e-05	3.62e-05	CcSEcCtD
Oxycodone—Vomiting—Epirubicin—hematologic cancer	1.14e-05	3.52e-05	CcSEcCtD
Oxycodone—Nausea—Methotrexate—hematologic cancer	1.14e-05	3.51e-05	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—hematologic cancer	1.14e-05	3.5e-05	CcSEcCtD
Oxycodone—Rash—Epirubicin—hematologic cancer	1.13e-05	3.49e-05	CcSEcCtD
Oxycodone—Dermatitis—Epirubicin—hematologic cancer	1.13e-05	3.49e-05	CcSEcCtD
Oxycodone—Headache—Epirubicin—hematologic cancer	1.13e-05	3.47e-05	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—hematologic cancer	1.1e-05	3.39e-05	CcSEcCtD
Oxycodone—Nausea—Epirubicin—hematologic cancer	1.07e-05	3.29e-05	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—hematologic cancer	1.06e-05	3.25e-05	CcSEcCtD
Oxycodone—Rash—Doxorubicin—hematologic cancer	1.05e-05	3.23e-05	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—hematologic cancer	1.05e-05	3.22e-05	CcSEcCtD
Oxycodone—Headache—Doxorubicin—hematologic cancer	1.04e-05	3.21e-05	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—hematologic cancer	9.88e-06	3.04e-05	CcSEcCtD
Oxycodone—CYP2D6—Metabolism—NUP98—hematologic cancer	7.21e-06	0.000141	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FN1—hematologic cancer	7.16e-06	0.00014	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYCS—hematologic cancer	7.16e-06	0.00014	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	7.11e-06	0.000139	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—hematologic cancer	7.09e-06	0.000138	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BAD—hematologic cancer	7.08e-06	0.000138	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	7.08e-06	0.000138	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	7.01e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADCY7—hematologic cancer	7e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOA3—hematologic cancer	7e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	6.95e-06	0.000136	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NUP214—hematologic cancer	6.95e-06	0.000136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	6.92e-06	0.000135	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—FHL2—hematologic cancer	6.91e-06	0.000135	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—hematologic cancer	6.9e-06	0.000135	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—hematologic cancer	6.87e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	6.87e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD80—hematologic cancer	6.87e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	6.85e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KIT—hematologic cancer	6.85e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	6.85e-06	0.000134	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTR—hematologic cancer	6.81e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.81e-06	0.000133	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.81e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AGRN—hematologic cancer	6.77e-06	0.000132	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	6.73e-06	0.000131	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	6.73e-06	0.000131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	6.71e-06	0.000131	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO2—hematologic cancer	6.67e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF2—hematologic cancer	6.58e-06	0.000128	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	6.56e-06	0.000128	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSC2—hematologic cancer	6.56e-06	0.000128	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREB1—hematologic cancer	6.52e-06	0.000127	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	6.49e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.47e-06	0.000126	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—hematologic cancer	6.44e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH2—hematologic cancer	6.42e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMMR—hematologic cancer	6.42e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—hematologic cancer	6.38e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6R—hematologic cancer	6.36e-06	0.000124	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	6.35e-06	0.000124	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SDC1—hematologic cancer	6.33e-06	0.000124	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.31e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	6.31e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAK2—hematologic cancer	6.31e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	6.25e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	6.18e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MDM2—hematologic cancer	6.15e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—hematologic cancer	6.13e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	6.06e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FN1—hematologic cancer	6.05e-06	0.000118	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.04e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	6.02e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	5.99e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MTOR—hematologic cancer	5.99e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BAD—hematologic cancer	5.98e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	5.98e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—hematologic cancer	5.97e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.97e-06	0.000116	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—hematologic cancer	5.96e-06	0.000116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	5.92e-06	0.000116	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	5.9e-06	0.000115	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA9—hematologic cancer	5.87e-06	0.000115	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ACP5—hematologic cancer	5.87e-06	0.000115	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD80—hematologic cancer	5.8e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.8e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.8e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.8e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	5.79e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KIT—hematologic cancer	5.79e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	5.79e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—hematologic cancer	5.77e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	5.72e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	5.69e-06	0.000111	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	5.69e-06	0.000111	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	5.62e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	5.56e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	5.55e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAK2—hematologic cancer	5.53e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CREBBP—hematologic cancer	5.52e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH1—hematologic cancer	5.52e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREB1—hematologic cancer	5.51e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—hematologic cancer	5.51e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—hematologic cancer	5.5e-06	0.000107	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—hematologic cancer	5.47e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TXN—hematologic cancer	5.46e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.46e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.46e-06	0.000107	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—hematologic cancer	5.44e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	5.42e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MDM2—hematologic cancer	5.4e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—hematologic cancer	5.39e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD44—hematologic cancer	5.38e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NQO1—hematologic cancer	5.38e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6R—hematologic cancer	5.38e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	5.37e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—hematologic cancer	5.36e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JUN—hematologic cancer	5.35e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.34e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MTOR—hematologic cancer	5.25e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	5.25e-06	0.000103	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	5.24e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	5.19e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—hematologic cancer	5.17e-06	0.000101	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—hematologic cancer	5.17e-06	0.000101	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.13e-06	0.0001	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	5.13e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.13e-06	0.0001	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	5.09e-06	9.94e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYCS—hematologic cancer	5.09e-06	9.94e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	5.06e-06	9.88e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.06e-06	9.88e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	5.05e-06	9.86e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.04e-06	9.85e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	5.01e-06	9.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.99e-06	9.75e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.99e-06	9.75e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	4.98e-06	9.73e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	4.95e-06	9.65e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—hematologic cancer	4.93e-06	9.63e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	4.93e-06	9.62e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	4.88e-06	9.52e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	4.87e-06	9.52e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.87e-06	9.5e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	4.83e-06	9.43e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—hematologic cancer	4.82e-06	9.41e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	4.81e-06	9.39e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—hematologic cancer	4.8e-06	9.37e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	4.8e-06	9.37e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NUP98—hematologic cancer	4.71e-06	9.2e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	4.7e-06	9.18e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JUN—hematologic cancer	4.69e-06	9.16e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	4.67e-06	9.12e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	4.67e-06	9.12e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	4.63e-06	9.03e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	4.62e-06	9.01e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.58e-06	8.94e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.57e-06	8.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.57e-06	8.93e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	4.56e-06	8.91e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	4.56e-06	8.9e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	4.55e-06	8.88e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NUP214—hematologic cancer	4.54e-06	8.87e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	4.54e-06	8.86e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.49e-06	8.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTR—hematologic cancer	4.45e-06	8.69e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.45e-06	8.69e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	4.44e-06	8.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	4.44e-06	8.66e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	4.44e-06	8.66e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	4.43e-06	8.64e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	4.42e-06	8.63e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO2—hematologic cancer	4.36e-06	8.52e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—hematologic cancer	4.33e-06	8.45e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.31e-06	8.41e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—hematologic cancer	4.3e-06	8.4e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	4.29e-06	8.37e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.25e-06	8.29e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	4.24e-06	8.27e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.23e-06	8.26e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—hematologic cancer	4.21e-06	8.22e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	4.16e-06	8.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDC1—hematologic cancer	4.14e-06	8.08e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.12e-06	8.05e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.12e-06	8.05e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	4.12e-06	8.04e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	4.1e-06	8e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	4.08e-06	7.97e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—hematologic cancer	4.08e-06	7.96e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	4.06e-06	7.92e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	4.06e-06	7.92e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	4.05e-06	7.9e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.99e-06	7.79e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	3.97e-06	7.76e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	3.97e-06	7.76e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JUN—hematologic cancer	3.96e-06	7.74e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—hematologic cancer	3.94e-06	7.7e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	3.88e-06	7.57e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.84e-06	7.5e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	3.83e-06	7.49e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.79e-06	7.39e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—hematologic cancer	3.77e-06	7.36e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—hematologic cancer	3.76e-06	7.34e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	3.76e-06	7.34e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	3.75e-06	7.32e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	3.74e-06	7.3e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—hematologic cancer	3.74e-06	7.3e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—hematologic cancer	3.66e-06	7.14e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.65e-06	7.13e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.64e-06	7.11e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.57e-06	6.98e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—hematologic cancer	3.56e-06	6.94e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—hematologic cancer	3.53e-06	6.89e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD44—hematologic cancer	3.52e-06	6.87e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NQO1—hematologic cancer	3.52e-06	6.87e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	3.48e-06	6.8e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	3.46e-06	6.76e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	3.43e-06	6.7e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	3.42e-06	6.68e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	3.38e-06	6.59e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYCS—hematologic cancer	3.33e-06	6.5e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.31e-06	6.46e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.3e-06	6.44e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	3.28e-06	6.4e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—hematologic cancer	3.23e-06	6.31e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	3.2e-06	6.25e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—hematologic cancer	3.19e-06	6.22e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	3.18e-06	6.21e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—hematologic cancer	3.1e-06	6.05e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.06e-06	5.98e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	2.98e-06	5.82e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	2.96e-06	5.78e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	2.94e-06	5.75e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.93e-06	5.73e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—hematologic cancer	2.85e-06	5.57e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.84e-06	5.54e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—hematologic cancer	2.83e-06	5.53e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.78e-06	5.43e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.78e-06	5.42e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—hematologic cancer	2.72e-06	5.31e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.71e-06	5.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.7e-06	5.26e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.7e-06	5.26e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.69e-06	5.26e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—hematologic cancer	2.66e-06	5.19e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.62e-06	5.11e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	2.62e-06	5.11e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.54e-06	4.96e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	2.5e-06	4.89e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—hematologic cancer	2.4e-06	4.68e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.38e-06	4.65e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.35e-06	4.58e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—hematologic cancer	2.27e-06	4.44e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	2.21e-06	4.31e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—hematologic cancer	2.03e-06	3.96e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.01e-06	3.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2e-06	3.91e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—hematologic cancer	1.93e-06	3.77e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.86e-06	3.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.76e-06	3.44e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—hematologic cancer	1.74e-06	3.39e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.66e-06	3.24e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—hematologic cancer	1.64e-06	3.21e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.53e-06	2.99e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.43e-06	2.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.33e-06	2.59e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—hematologic cancer	1.26e-06	2.47e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.17e-06	2.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.35e-07	1.83e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—hematologic cancer	7.64e-07	1.49e-05	CbGpPWpGaD
